Russia plans to grant temporary approval to a new recombinant allergy vaccine in the second quarter of 2026, as clinical trials advance toward their final stage
Ukraine’s president offered an unprecedented look at his underground wartime shelter while reiterating positions on ceasefire guarantees, European integration, and the timing of future elections.